What is Trans Aortic Valve Replacement (TAVR)?
TAVR is a minimally invasive cardiac procedure to treat severe aortic stenosis, especially in older or high-risk patients who are not ideal candidates for open-heart surgery. It involves inserting a new aortic valve via a catheter, typically through the femoral artery in the groin, without opening the chest.
Common indications include:
- Severe symptomatic aortic stenosis
- Age >70 or frailty
- Comorbidities (kidney disease, previous heart surgery, etc.)
- Left ventricular ejection fraction <40%
The procedure typically lasts 1–2 hours, and most patients are discharged within 2–5 days. Success rates range from 95–98%, with improved quality of life, symptom relief (e.g., chest pain, fatigue), and reduced risk of heart failure.
Why Choose India for TAVR?
India is a rising hub for advanced cardiac interventions, offering world-class cardiac care at affordable costs. Patients from around the globe choose Delhi and NCR for TAVR because of:
- Experienced cardiologists and heart teams trained in top global centers
- State-of-the-art hybrid operating rooms and imaging systems
- Shorter waiting times and streamlined care for international patients
- Cost-effective care (70–80% less than Western nations)
Leading hospitals in Delhi-NCR offering TAVR include:
- Fortis Escorts Heart Institute (Okhla, Delhi)
- Medanta – The Medicity (Gurugram)
- Max Super Speciality Hospital (Saket, Delhi)
- Apollo Hospitals (Delhi)
These hospitals have dedicated Heart Valve Clinics, multidisciplinary teams, and international patient services to ensure seamless treatment journeys.
Cost & Duration Summary
Average Cost in India: USD 20,000 – 40,000
Hospital Stay Required: 1 – 3 days
Post-Treatment Stay in India: 2 – 4 weeks